Pharma Tips

Alembic & Torrent gain on USFDA nod for Generic Abilify (Aripiprazole)

By: Pharma News | Views: 1290 | Date: 19-May-2015

Alembic Pharma and Torrent Pharma are trading on a firm note following the early morning rally after the US FDA approved some of its new drugs. According to a release issued on the US FDA (Food and Drug Administration) website, the US FDA has approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder.



Alembic, Torrent get New Generic Drug Approval Abilify (Aripiprazole)

Alembic Pharma and Torrent Pharma are trading on a firm note following the early morning rally after the US FDA approved some of its new drugs. According to a release issued on the US FDA (Food and Drug Administration) website, the US FDA has approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder. 

The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder. 

Alembic Pharmaceuticals Ltd., Hetero Labs Ltd., Teva Pharmaceuticals and Torrent Pharmaceuticals Ltd. have received FDA approval to market generic aripiprazole in multiple strengths and dosage forms.

“Having access to treatments is important for patients with long-term health conditions,” said John Peters, M.D., acting director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research. “Health care professionals and consumers can be assured that FDA-approved generic drugs have met the same rigorous standards as the brand-name drug.”

Schizophrenia is a chronic, severe and disabling brain disorder. About one percent of Americans have this illness. Typically, symptoms are first seen in adults younger than 30 years of age. Symptoms of schizophrenia include hearing voices, believing other people are reading their minds or controlling thoughts and being suspicious or withdrawn.

Bipolar disorder, also known as manic-depressive illness, is another brain disorder that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks. The symptoms of bipolar disorder include alternating periods of depression and high or irritable mood, increased activity and restlessness, racing thoughts, talking fast, impulsive behavior and a decreased need for sleep.

All atypical antipsychotics contain a Boxed Warning alerting health care professionals about an increased risk of death associated with the off-label use of these drugs to treat behavioral problems in older people with dementia-related psychosis. No drug in this class is approved to treat patients with dementia-related psychosis.

Aripiprazole’s Boxed Warning also warns about an increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants. Patients should be monitored for worsening and emergence of suicidal thoughts and behaviors. Aripiprazole must be dispensed with a patient Medication Guide that describes important information about the drug’s uses and risks.

In the clinical trials for Abilify, the most common side effects reported by adults taking Abilify were nausea, vomiting, constipation, headache, dizziness, uncontrollable limb and body movements (akathisia), anxiety, insomnia, and restlessness.

Generic prescription drugs approved by the FDA have the same high quality and strength as brand-name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals have received FDA approval to market generic aripiprazole in multiple strengths and dosage forms, the release added. Alembic Pharma soared over 10 percent to touch a high at Rs. 496, and is now up 6.6 percent at Rs. 480. The counter has seen trades of around 73,000 shares as against the two-week daily average volume of around 48,000 shares on the BSE.

Torrent Pharma zoomed nearly 11 percent to a high of Rs. 1,323, and is now up 3.1 percent at Rs. 1,230. Around 26,000 shares have changed hands at the counter so far on the BSE, almost 3-times higher when compared with its two-week daily average volume of around 9,000-odd shares. 

Meanwhile, the Sensex has recouped some of the losses and is now down 146 points at 27,251. 
Previous Page Next Page

People Searching On This Page:
  • b.pharme ebilriy
  • images on FDA
  • where is the best treatment for pschizophrenia in ankleshwar bharuch

Related Pages


R&D Jobs in Torrent Research Centre @ Torrent Pharma

R&D Jobs in Torrent Research Centre @ Torrent Pharma

Jobs | R & D | Ahmedabad
Date:
10-Apr-2015  Views: 6954

Torrent Pharmaceuticals Ltd.The flagship company of the Torrent Group, Torrent Pharmaceuticals Limited is a major player in the Indian pharmaceuticals ...
Quality Assurance Jobs in Sun Pharma,Torrent,Alembic,Zydus,Cipla,Intas

Quality Assurance Jobs in Sun Pharma,Torrent,Alembic,Zydus,Cipla,Intas

Jobs | Quality Assurance | Gujarat
Date:
09-Apr-2015  Views: 9297

Quality Assurance Jobs in Sun Pharma,IPCA,Cipla,Torrent,Lupin,Glenmark,Intas,Alembic,Dishman,Cadila,Zydus, Cadila,Unichem,Sun Pharma,Unimark Remedies ...
Zydus Cadila Gets USFDA Nod for Kidney Stones Tablets

Zydus Cadila Gets USFDA Nod for Kidney Stones Tablets

News | FDA
Date:
14-Aug-2014  Views: 1684

Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidne ...
Gleevec Medicines Fight against Cancer

Gleevec Medicines Fight against Cancer

News | Pharmaceutical Drugs
Date:
14-Oct-2013  Views: 1380

How does Gleevec work? What will it do for me?How should I use Gleevec?What form(s) does Gleevec come in?Who should NOT take Gleevec?What side effects ...
Glenmark gets USFDA nod for alcohol abstinence drug

Glenmark gets USFDA nod for alcohol abstinence drug

News | FDA
Date:
14-Aug-2013  Views: 8408

Glenmark Pharmaceuticals today said it has received US health regulator's approval to market generic version of Forest Laboratories' Campral Delayed R ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

32  + 6 =     
Comments
People Searched About:
B.Pharme Ebilriy   |   Images On FDA   |   Where Is The Best Treatment For Pschizophrenia In Ankleshwar Bharuch   |  
Google : 162 times | Yahoo : 14 times | Bing : 13 times |